Table 2 Tactic table for primary adversary (dealers in SF chemotherapies)
Expected outcome: Avoid adversaries blocking ethical and regulatory approvals for testing chemoPAD in cancer treatment centers as well as conducting the research in Cameroon | |
|---|---|
Major issue occupying stakeholders: Approval for the use of chemoPAD to screen for quality of anticancer drugs may lead to a disruption of a long-standing & viable business | |
Tactic | Response |
Deploy strategies to solve adversary’s problem to garner influence for horse trading | No |
Deploy strategies to aggravate the adversary’s position | No |
Reward adversary for cessation of opposition | No |
Leverage support from allies or ally’s allies to mitigate antagonism or protect project from adversary | No |
Identify a protected niche where adversary has no influence | University teaching hospitals and oncologies are interested in seeing desired outcomes in patients receiving chemotherapy |